amfAR, The Foundation for AIDS Research

amfAR institute banner large

“We intend to quicken the pace of cure research by supporting a collaborative community of leading HIV researchers in one cohesive enterprise.” - Kevin Robert Frost, amfAR Chief Executive Officer

An Exciting New Research Collaboration

Launched on the eve of World AIDS Day 2015, the amfAR Institute for HIV Cure Research is the centerpiece of our $100 million investment strategy aimed at developing the scientific basis of a cure by the end of 2020.

Established with a five-year $20 million grant to the University of California, San Francisco, the Institute brings together many of the finest minds and most experienced researchers working in the field today.  

Under the direction of renowned AIDS researcher Dr. Paul Volberding, teams of investigators are working collaboratively to address the scientific challenges that stand in the way of a cure.

 Institute Director Dr. Paul Volberding 
Institute Director Dr. Paul Volberding

What’s New at the Institute?

UCSF Loses a Revered HIV Scientist

Gutting HIV

Researchers Report Progress at Cure Summit

Lab Chat: An Interview with Dr. Shomyseh Sanjabi

More ‘Shocks’ in Strategies to Kill Latent HIV

Using Mice to Detect ‘Undetectable HIV’

Aging with HIV: Concerns About Accelerated Heart Disease

Investigators at amfAR Institute for HIV Cure Research deliver progress report

HIV Cure Research Roundup  

A New Take on an Old Vaccine Idea

Progress, Plans, and the Prospects for a Cure


About the amfAR Institute

amfAR Establishes San Francisco-Based Institute for HIV Cure Research

amfAR Institute for HIV Cure Research: The Work Ahead

Principal Investigators and Collaborating Institutions

Our Moonshot by amfAR CEO Kevin Robert Frost

amfAR’s Countdown to a Cure for AIDS Initiative

amfAR Announces $100 Million Investment Strategy Aimed at Curing HIV